A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

NCT07414836 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: BG-C0979
DRUG: Tislelizumab

Sponsor

BeOne Medicines